Estimating the risks of ovarian hyperstimulation syndrome (OHSS): implications for egg donation for research.

Newcastle Fertility Centre at Life, International Centre for Life, Newcastle upon Tyne, UK.
Human Fertility (Impact Factor: 1.02). 09/2007; 10(3):183-7. DOI: 10.1080/14647270601021743
Source: PubMed

ABSTRACT This study aims to provide an estimate of women's risk of ovarian hyperstimulation syndrome (OHSS) when undergoing superovulation to donate eggs for research. This is an essential prerequisite for appropriate informed consent. In the absence of sufficiently large numbers of egg donors to assess the risk, comparative data was obtained from women undergoing the same superovulation protocol for in vitro fertilization (IVF) treatment. In this prospective study 339 women, who developed >/=20 follicles after superovulation in their first treatment cycle (total number of treatment cycles during the same period - 2417), were intensively monitored on five occasions, between human chorionic gonadotrophin and pregnancy test, according to our routine clinical protocol. Hospital admission was needed for 49 (14.5%) women, 13 (3.8%) needed intravenous fluids and 9 (2.7%) needed paracentesis. The admission rates were similar in pregnant and non-pregnant women (13.5% vs. 15%); the need for intravenous fluids and paracentesis were 3.2% vs. 2.3% and 6.3% vs. 2.3%, respectively. The peak increase in haematocrit occurred on Day 4 after hCG, and the mean day of hospital admission was Day 5. If an egg donor develops <20 follicles, she can be reassured that the risk of OHSS is very small (<0.1%). If >/=20 follicles develop, her risk of hospital admission due to OHSS is <15%. The absence of pregnancy in egg donors does not eliminate the risk of OHSS. Given the timescale of development of the haematological and biochemical abnormalities, egg donors who develop >/=20 follicles should be actively monitored for the first week after egg collection.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Judges and public policy makers have transmitted conflicting messages in relation to women's bodies and have made normative judgements about how women are to appear in public. Women who have been judged to be wearing too much are called to undress as they are seen as interfering with the rights of others or being oppressed. Women judged to be wearing too little are urged to clothe themselves to avoid being seen as inviting sexual assault or dressing like always sexually available prostitutes. Juxtaposing these two situations, the oddness of judicial and public regulation of women's clothing becomes more starkly exposed. This paper examines the shifting nature of equality discourse and the naming of women's oppression; the near-disappearance of patriarchy as an explanatory framework; and the quagmire of women's agency. The concluding section proposes shifting the focus from differences between women's experiences to similarity in order to facilitate critical inquiry, dialogue and strategic action that might reconstitute women's equality in new ways.
    Social Identities 11/2013; 19(6). DOI:10.1080/13504630.2013.842671
  • [Show abstract] [Hide abstract]
    ABSTRACT: This study analyzes 435 oocyte donor recruitment advertisements to assess whether entities recruiting donors of oocytes to be used for in vitro fertilization (IVF) procedures include a disclosure of risks associated with the donation process in their advertisements. Such disclosure is required by the self-regulatory guidelines of the American Society for Reproductive Medicine (ASRM) and by law in California for advertisements placed in the state. We find very low rates of risk disclosure across entity types and regulatory regimes, although risk disclosure is more common in advertisements placed by entities subject to ASRM's self-regulatory guidelines. Advertisements placed in California are more likely to include risk disclosure, but disclosure rates are still quite low. California-based entities advertising outside the state are more likely to include risk disclosure than non-California entities, suggesting that California's law may have a modest “halo effect.” Our results suggest that there is a significant ethical and policy problem with the status quo in light of the known and unknown risks of oocyte donation and the importance of risk disclosure to informed consent in the context of oocyte donation.
    The Journal of Law Medicine &amp Ethics 06/2014; 42(2). DOI:10.1111/jlme.12138 · 0.94 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The spectacular progress in assisted reproduction technology that has been witnessed for the past thirty years resulted in emerging new ethical dilemmas as well as the revision of some perennial ones. The paper aims at a feminist approach to oocyte and spare embryo donation for research. First, referring to different concepts of autonomy and informed consent, we discuss whether the decision to donate oocyte/embryo can truly be an autonomous choice of a female patient. Secondly, we argue the commonly adopted language of gift is misleading and that calling for altruism could put female patients at risk of exploitation. Finally, we point out that the presence of gender stereotypes in the procreative area casts doubt whether even a more robust notion of informed consent manages to overcome this risk.
    Medicine Health Care and Philosophy 09/2013; 17(1). DOI:10.1007/s11019-013-9513-1 · 0.91 Impact Factor


Available from
May 26, 2014